Antidepressive-like property of dichloromethane fraction of pimenta pseudocaryophyllus and relevance of monoamine metabolic enzymes

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Fajemiroye, James Oluwagbamigbe ^a   Martins, José Luís Rodrigues ^a   Ghedini, Paulo César ^a   Galdino, Pablinny Morreira ^b   Paula, Joelma Abadia Marciano De ^c   Realino De Paula, José ^a   Da Rocha, Fabio Fagundes ^d   Costa, Elson Alves ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSIDADE ESTADUAL DE GOIÁS   (Brazil)

^d FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; DIAZEPAM; DICHLOROMETHANE; FENCLONINE METHYL ESTER; IMIPRAMINE; METIROSINE; MONOAMINE; TRANYLCYPROMINE; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ASSAY; ENZYME DEGRADATION; ENZYME INHIBITION; EX VIVO STUDY; FORCED SWIMMING TEST; MALE; MONOAMINE METABOLISM; MOUSE; NONHUMAN; OPEN FIELD TEST; PIMENTA; PIMENTA PSEUDOCARYOPHYLLUS; PRIORITY JOURNAL; REARING; TAIL FLICK TEST;

EID: 84873328692     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/659391     Document Type: Article

References (54)

1. Landrum L. R., Monography 45: campomanesia, pimenta, blepharocalyx, legrandia, acca, myrrhinium, and luma (Myrtaceae). Flora Neotropica 1986 4 72 115
2. Landrum L. R., Kawasaki M. L., The genera of Myrtaceae in Brazil: an illustrated synoptic treatment and identification keys. Brittonia 1997 49 4 508 536 2-s2.0-0031447952 (Pubitemid 28155731)
3. Nakaoka-Sakita M., Aguiar O. T., Yatagai M., Igarashi T., Óleo essencial de Pimenta pseudocaryophyllus var. pseudocaryophyllus (Gomes) Landrum (Myrtaceae) I: cromatografia a gás/espectrometria de massa (CC/EM). A Revista do Instituto Florestal 1994 6 53 61
4. Lima M. E. L., Cordeiro I., Young M. C. M., Sobra M. E. G., Moreno P. R. H., Antimicrobial activity of the essential oil from two specimens of Pimenta pseudocaryophyllus (Gomes) L.R. Landrum (Myrtaceae) native from São Paulo State-Brazil. Pharmacologyonline 2006 3 589 593
5. Paula J. A. M., Paula J. R., Bara M. T. F., Rezende M. H., Ferreira H. D., Pharmacognostic study about Pimenta pseudocaryophyllus (Gomes) L. R. Landrum leaves-Myrtaceae. Revista Brasileira de Farmacognosia 2008 18 2 265 278 10.1590/S0102-695X2008000200022
6. dos Santos B. C. B., da Silva J. C. T., Guerrero P. G., Leitão G. G., Barata L. E. S., Isolation of chavibetol from essential oil of Pimenta pseudocaryophyllus leaf by high-speed counter-current chromatography. Journal of Chromatography A 2009 1216 19 4303 4306 2-s2.0-64249111986 10.1016/j.chroma. 2009.01.111
7. Fajemiroye J. O., Araujo E. S., Galdino P. M., Brito A. F., Paula J. A. M., Paula J. R., Costa E. A., Alterações comportamentais induzidas pelo óleo essencial extraído das folhas de Pimenta pseudocaryophyllus (Gomes) L. R. Landrum. 121 XXI Simpósio de Plantas Medicinais do Brasil. Plantas Medicinais 2010 Avanços, Brasil Utilização e Conservação
8. Fajemiroye J. O., Galdino P. M., Alves S. F., de Paula J. A., de Paula J. R., Ghedini P. C., Costa E. A., Involvement of 5-HT1A in the anxiolytic-like effect of dichloromethane fraction of Pimenta pseudocaryophyllus. Journal of Ethnopharmacology 2012 3 872 877
9. Fajemiroye J. O., Martins J. L. R., Brito A. F., Paula J. A. M., Paula J. R., Costa E. A., Neuropharmacological activity of Pimenta pseudocaryophyllus (Gomes) L.R. Landrum. Planta Medica 2011 77 1401
10. Blier P., The pharmacology of putative early-onset antidepressant strategies. European Neuropsychopharmacology 2003 13 2 57 66 2-s2.0-0037338273 10.1016/S0924-977X(02)00173-6 (Pubitemid 36313278)
11. Antony M. M., Assessment and treatment of social phobia. Canadian Journal of Psychiatry 1997 42 826 834 (Pubitemid 27521141)
12. Sheehan D. V., Mao C. G., Paroxetine treatment of generalized anxiety disorder. Psychopharmacology Bulletin 2003 37 64 75
13. Zohar J., Westenberg H. G., Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica 2000 supplement 403 39 49
14. Kalus O., Asnis G. M., Rubinson E., Kahn R., Harkavy Friedman J. M., Iqbal N., Grosz D., Van Praag H., Cahn W., Desipramine treatment in panic disorder. Journal of Affective Disorders 1991 21 4 239 244 2-s2.0-0025872624 10.1016/0165-0327(91)90003-B
15. Katon W., Panic disorder: epidemiology, diagnosis, and treatment in primary care. Journal of Clinical Psychiatry 1986 47 21 30
16. Jann M. W., Kurtz N. M., Treatment of panic and phobic disorders. Clinical Pharmacy 1987 6 947 962 (Pubitemid 18007446)
17. Trivedi M. H., Rush A. J., Carmody T. J., Donahue R. M. J., Bolden-Watson C., Houser T. L., Metz A., Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? Journal of Clinical Psychiatry 2001 62 10 776 781 2-s2.0-0035190830 (Pubitemid 33104664)
18. Rush A. J., Trivedi M. H., Carmody T. J., Donahue R. M. J., Houser T. L., Bolden-Watson C., Batey S. R., Ascher J. A., Metz A., Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline. Neuropsychopharmacology 2001 25 1 131 138 2-s2.0-0035017807 10.1016/S0893-133X(00)00249-9 (Pubitemid 32493829)
19. Hattesohl M., Feistel B., Sievers H., Lehnfeld R., Hegger M., Winterhoff H., Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 2008 15 1-2 2 15 2-s2.0-37549018503 10.1016/j.phymed.2007.11.027 (Pubitemid 50021760)
20. Braida D., Capurro V., Zani A., Rubino T., Viganò D., Parolaro D., Sala M., Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. British Journal of Pharmacology 2009 157 5 844 853 2-s2.0-70350166693 10.1111/j.1476-5381.2009. 00230.x
21. Steru L., Chermat R., Thierry B., Simon P., The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985 85 3 367 370 2-s2.0-0021990491 (Pubitemid 15123115)
22. Porsolt R. D., Bertin A., Jalfre M., Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 1977 229 2 327 336 2-s2.0-0017651126 (Pubitemid 8225714)
23. Holt A., Sharman D. F., Baker G. B., Palcic M. M., A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Analytical Biochemistry 1997 244 2 384 392 2-s2.0-0031568289 10.1006/abio.1996.9911 (Pubitemid 27043336)
24. Zhou B., Li X., Qiu Z., Liu G., Effect of leaves of Apocynum venetum L. on the activity of MAO in mice. Journal of Medicinal Plant Research 2011 5 12 2584 2586 2-s2.0-79960736133
25. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
26. Drummond G. B., Tom B. D. M., How can we tell if frogs jump further? British Journal of Pharmacology 2011 164 209 212 10.1111/j.1476-5381.2011.01493. x
27. Drummond G. B., Tom B. D. M., Statistics, probability, significance, likelihood: words mean what we define them to mean. British Journal of Pharmacology 2011 164 1573 1576 10.1111/j.1476-5381.2011.01577.x
28. Paula J. A. M., Silva M. R. R., Costa M. P., Diniz D. G. A., Sá F. A. S., Alves S. F., Costa E. A., Lino R. C., Paula J. R., Phytochemical analysis and antimicrobial, antinociceptive, and anti-inflammatory activities of two chemotypes of Pimenta pseudocaryophyllus (Myrtaceae). Evidence-Based Complementary and Alternative Medicine 2012 2012 15 420715 10.1155/2012/420715
29. Connor T. J., Kelly J. P., Leonard B. E., Forced swim test-induced endocrine and immune changes in the rat: Effect of subacute desipramine treatment. Pharmacology Biochemistry and Behavior 1998 59 1 171 177 2-s2.0-0031973071 10.1016/S0091-3057(97)00316-X (Pubitemid 28053695)
30. Cryan J. F., Markou A., Lucki I., Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 2002 23 5 238 245 2-s2.0-0036570222 10.1016/S0165-6147(02)02017-5 (Pubitemid 34465544)
31. Frazer A., Benmansour S., Delayed pharmacological effects of antidepressants. Molecular Psychiatry 2002 7 S23 S28 10.1038/sj.mp.4001015 (Pubitemid 34280645)
32. Nelson J. C., Mazure C. M., Jatlow P. I., Bowers M. B. Jr., Price L. H., Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biological Psychiatry 2004 55 3 296 300 2-s2.0-1642523483 10.1016/j.biopsych.2003.08.007 (Pubitemid 38117167)
33. Wong M. L., Licinio J., Research and treatment approaches to depression. Nature Reviews Neuroscience 2001 2 343 351 10.1038/35072566 (Pubitemid 33680576)
34. Geyer M., Markou A., Bloom F., Kupfer D., Secondary animal models of psychiatric disorders. Psychopharmacology: The Fourth Generation of Progress 1995 New York, NY, USA Raven Press 787 798
35. West A. P., Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Progress in Neuro- Psychopharmacology and Biological Psychiatry 1990 14 863 877 10.1016/0278-5846(90)90073-P (Pubitemid 20373158)
36. Castagné V., Moser P., Roux S., Porsolt R. D., Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Current Protocols in Neuroscience. In press 10.1002/0471142301.ns0810as55
37. Detke M. J., Johnson J., Lucki I., Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Experimental and Clinical Psychopharmacology 1997 5 2 107 112 2-s2.0-0030963916 10.1037/1064-1297.5.2.107 (Pubitemid 27239810)
38. Bodnoff S. R., Suranyi-Cadotte B., Aitken D. H., Quirion R., Meaney M. J., The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 1988 95 3 298 302 2-s2.0-0023947879
39. Aragão G. F., Carneiro L. M. V., Junior A. P. F., Vieira L. C., Bandeira P. N., Lemos T. L. G., Viana G. S. D. B., A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March. Pharmacology Biochemistry and Behavior 2006 85 4 827 834 2-s2.0-33846439353 10.1016/j.pbb.2006.11.019 (Pubitemid 46149011)
40. Zhou Y., Shen Y. H., Zhang C., Su J., Liu R. H., Zhang W. D., Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models. Journal of Natural Products 2007 70 4 652 655 2-s2.0-34249059981 10.1021/np060470s (Pubitemid 46797873)
41. Maia J. L., Lima-Júnior R. C. P., David J. P., David J. M., Santos F. A., Rao V. S., Oleanolic acid, a pentacyclic triterpene attenuates the mustard oil-induced colonic nociception in mice. Biological and Pharmaceutical Bulletin 2006 29 1 82 85 2-s2.0-29844453901 10.1248/bpb.29.82 (Pubitemid 43036699)
42. Charney D. S., Monoamine dysfunction and the pathophysiology and treatment of depression. Journal of Clinical Psychiatry 1998 59 11 14 (Pubitemid 28462383)
43. Miller H. L., Delgado P. L., Salomon R. M., Berman R., Krystal J. H., Heninger G. R., Charney D. S., Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Archives of General Psychiatry 1996 53 2 117 128 2-s2.0-0030030571 (Pubitemid 26049388)
44. Zhao Z., Baros M. A., Zhang H., Lapiz D. S. M., Bondi O. C., Morilak A. D., 'Donnell M. J. O., Norepinephrine transporter regulation mediates the long- term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology 2008 33 3190 3200 10.1038/npp.2008.45
45. Whitaker-Azmitia P. M., Borella A., Raio N., Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia. Neuropsychopharmacology 1995 12 3 269 272 2-s2.0-0029059048 10.1016/0893-133X(94)00081-A
46. Miller H. L., Delgado P. L., Salomon R. M., Heninger G. R., Charnery D. S., Effects of alpha-methyl-para-tyrosine (AMPT) in drug free depressed patients. Neuropsychopharmacology 1996 14 151 157 10.1016/0893-133X(95)00072-L (Pubitemid 26099085)
47. Lam R. W., Tam E. M., Grewal A., Yatham L. N., Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission. Neuropsychopharmacology 2001 25 5 S97 S101 2-s2.0-0034771586 10.1016/S0893-133X(01)00337-2 (Pubitemid 33000278)
48. Salomon R. M., Miller H. L., Delgado P. L., Charney D., The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders. International Clinical Psychopharmacology 1993 supplement 2 41 46 (Pubitemid 24063806)
49. Millan M. J., Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacology & Therapeutics 2006 110 135 370 10.1016/j.pharmthera.2005.11.006
50. Knoll J., The history of (-)deprenyl the first selective inhibitor of type B monoamine oxidase. Voprosy Meditsinskoj Khimii 1997 43 6 490 493 2-s2.0-3943074534 (Pubitemid 127570247)
51. Wouters J., Structural aspect of monoamine oxidaseand its reversible inhibition. Current Medicinal Chemistry 1988 5 137 162
52. Butterweck V., Mechanism of action of St John's wort in depression: what is known? CNS Drugs 2003 17 8 539 562 2-s2.0-0037698961 (Pubitemid 36774135)
53. Murphy D. L., Karoum F., Pickar D., Cohen R. M., Lipper S., Mellow A. M., Tariot P. N., Sunderland T., Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). Journal of Neural Transmission 1998 supplement 52 39 48 2-s2.0-0031596683 (Pubitemid 28175321)
54. Williams A. D., Antidepressants. Principles of Medicinal Chemistry 2007 Hagerstwon, Md, USA Lippincott Williams & Wilkins 590 591